中华胃肠外科杂志
中華胃腸外科雜誌
중화위장외과잡지
CHINESE JOURNAL OF GASTROINTESTINAL SURGERY
2011年
12期
938-940
,共3页
雷超%王业皇%张苏闽%江平%焦学信%黄和艮
雷超%王業皇%張囌閩%江平%焦學信%黃和艮
뢰초%왕업황%장소민%강평%초학신%황화간
小麦纤维素%肛门良性疾病%排粪异常%排粪症状评分
小麥纖維素%肛門良性疾病%排糞異常%排糞癥狀評分
소맥섬유소%항문량성질병%배분이상%배분증상평분
Fiberform%Anus benign lesion%Abnormal defecation%Defecation symptom scores
目的 探讨小麦纤维素对肛门良性病变手术后排粪情况的影响.方法 将2009年10月至2010年2月间南京中医药大学附属第三医院收治的121例肛门良性病变手术患者按随机数字表法分为试验组(61例)和对照组(60例).试验组口服小麦纤维素颗粒2周,对照组不采用任何泻药;比较两组术后排粪症状评分及患者满意度.结果术后7d,试验组较对照组排粪通畅度积分下降率为62.1%,粪便性状积分下降率为74.3%,排粪间隔积分下降率为80.2%,排粪疼痛积分下降率为77.5%,差异均有统计学意义(均P<0.05);术后14 d,试验组上述症状积分下降率分别为58.3%、88.5%、82.8%和83.1%,差异均有统计学意义(均P<0.01).术后试验组患者满意度明显高于对照组(P<0.05).治疗组无一例患者出现腹痛、腹泻及药物依赖性等不良事件发生.结论小麦纤维素可有效预防肛门良性疾病术后粪便干燥、排粪不畅、肛门疼痛等排粪障碍.
目的 探討小麥纖維素對肛門良性病變手術後排糞情況的影響.方法 將2009年10月至2010年2月間南京中醫藥大學附屬第三醫院收治的121例肛門良性病變手術患者按隨機數字錶法分為試驗組(61例)和對照組(60例).試驗組口服小麥纖維素顆粒2週,對照組不採用任何瀉藥;比較兩組術後排糞癥狀評分及患者滿意度.結果術後7d,試驗組較對照組排糞通暢度積分下降率為62.1%,糞便性狀積分下降率為74.3%,排糞間隔積分下降率為80.2%,排糞疼痛積分下降率為77.5%,差異均有統計學意義(均P<0.05);術後14 d,試驗組上述癥狀積分下降率分彆為58.3%、88.5%、82.8%和83.1%,差異均有統計學意義(均P<0.01).術後試驗組患者滿意度明顯高于對照組(P<0.05).治療組無一例患者齣現腹痛、腹瀉及藥物依賴性等不良事件髮生.結論小麥纖維素可有效預防肛門良性疾病術後糞便榦燥、排糞不暢、肛門疼痛等排糞障礙.
목적 탐토소맥섬유소대항문량성병변수술후배분정황적영향.방법 장2009년10월지2010년2월간남경중의약대학부속제삼의원수치적121례항문량성병변수술환자안수궤수자표법분위시험조(61례)화대조조(60례).시험조구복소맥섬유소과립2주,대조조불채용임하사약;비교량조술후배분증상평분급환자만의도.결과술후7d,시험조교대조조배분통창도적분하강솔위62.1%,분편성상적분하강솔위74.3%,배분간격적분하강솔위80.2%,배분동통적분하강솔위77.5%,차이균유통계학의의(균P<0.05);술후14 d,시험조상술증상적분하강솔분별위58.3%、88.5%、82.8%화83.1%,차이균유통계학의의(균P<0.01).술후시험조환자만의도명현고우대조조(P<0.05).치료조무일례환자출현복통、복사급약물의뢰성등불량사건발생.결론소맥섬유소가유효예방항문량성질병술후분편간조、배분불창、항문동통등배분장애.
Objective To explore the influence of fiberform on the defecation condition after surgery for benign anorectal lesion.Methods A total of 121 cases undergoing surgery for benign anorectal lesion at the Third Affiliated Hospital of Nanjing University of Traditional Chinese Medicine from October 2009 to February 2010 were randomly divided into the treatment group (n=61) and the control group (n=60) according to random number table.Patients in the treatment group received fiberform granule for 2 weeks while patients in the control group did not receive any medication to promote defecation.Postoperative defecation symptom scores and patient satisfaction were compared between the two groups.Results On postoperative day 7,patients in the treatment group had a lower defecation smoothness score (62.1% decrease),lower fecal character score (74.3% decrease),lower defecation interval score (80.2% decrease),lower defecation pain score (77.5% decrease),the differences were statistically significant.On postoperative day 14,the degree of decrease of the abovementioned score were 58.3%,88.5%,82.8% and 83.1%,respectively.Postoperative patient satisfaction rate in the treatment group was significantly higher than that in the control group (P<0.05).No patient in the treatment group experienced any adverse events such as abdominal pain,diarrhea,and drug dependence.Conclusion Fiberform can effectively prevent defecation disorders such as dry stool,unsmooth defecation,and anorectal pain.